Prevención y tratamiento de infección por trichomonas vaginalis en mujeres durante la atención primaria

Abstract

Trichomonas vaginalis (T. vaginalis) is the protozoan parasite that causes the most common curable sexually transmitted infection (STI) in the world called trichomoniasis. Trichomoniasis is the most common STI in sexually active young men and women. The World Health Organization (WHO) estimated 156 million cases of trichomoniasis worldwide in 2016. One of the least known STIs (survey of women aged 12 to 49 in Ecuador) is trichomoniasis (14.7%). Objective: To analyze the prevention and treatment of infection by T. vaginalis in women, through bibliographic review, for an adequate approach to patients during primary care. Methodology: A descriptive systematic research was carried out, through the collection of information and statistical data in scientific articles published in the databases of Pubmed, Elsevier and Cochrane, using an analytical selection of bibliographic sources of the last 5 years with scientific significance. Conclusion: 7-day treatment with oral metronidazole (MTZ) is better than single-dose treatment for trichomoniasis among HIV negative women due to the lower failure rate.